Grigeo (GRG1L) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jun, 2025Executive summary
Revenue rose by EUR 10.5 million (22%) year-over-year to EUR 59.1 million for Q1 2025.
EBITDA increased slightly by EUR 0.1 million (1%) to EUR 7.5 million.
Profit before tax (EBT) decreased by EUR 0.7 million (13%) to EUR 4.5 million.
Financial highlights
Net profit for Q1 2025 was EUR 4.5 million, up from EUR 4.2 million in Q1 2024.
Gross margin declined to 19.8% from 24.0% year-over-year.
Basic and diluted EPS were EUR 0.034, up from EUR 0.033 and EUR 0.032, respectively.
Cash and cash equivalents increased to EUR 19.3 million from EUR 14.0 million at year-end 2024.
Adjusted EBITDA for Q1 2025 was EUR 7.5 million, nearly flat year-over-year.
Outlook and guidance
No significant changes in risk factors or uncertainties are expected for the remainder of 2025.
No material events occurred after the reporting period.
Latest events from Grigeo
- Revenue up 16% YoY, but profit and margins fell; expansion and legal risks remain.GRG1L
Q4 202525 Feb 2026 - Revenue up 9% but margins and net profit declined amid legal and geopolitical risks.GRG1L
Q3 202521 Nov 2025 - Revenue up 12% but profit and margins down; EUR 106m tissue investment planned.GRG1L
Q2 202522 Aug 2025 - Revenue up, but profit and margins down; legal and geopolitical risks remain elevated.GRG1L
Q3 202413 Jun 2025 - EBITDA and net profit fell despite revenue growth, with margin pressure and legal risks ongoing.GRG1L
Q2 202413 Jun 2025 - Revenue up 9% but profit down 13% amid margin pressure and legal risks.GRG1L
Q4 20246 Jun 2025